Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Thomas J Whitaker Image

      Thomas J Whitaker, PHD

      Department of Radiation Physics, Division of Radiation Oncology

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Radiation Physics, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Associate Professor, Radiation Physics - Pt Care, University of Texas MD Anderson Cancer Center, Houston, TX

      Research Interests

      My research interest are in outcomes research and knowledge based planning. This includes novel methods for constructing large datasets, machine learning, and deep learning techniques to perform patient outcomes research as well as knowledge based planning. I have a secondary interest in applying outcomes research and knowledge based planning to novel therapies such as particle therapy and hypo-fractionated radiotherapy. I utilize the programming languages: R, Python, C#, F#, SQL, Tableau, and the Varian Eclipse API to further my research.

      Clinical Interests

      I have a full spectrum of radiation therapy clinical practice experience which include: proton therapy using Varian treatment planning systems and Hitachi Pro-Beat delivery system, utilization and care of Elekta, Varian, and Cyberknife linear accelerator systems, utilization and care of Varisource remote after loader, installation and maintenance of Pinnicle, Eclipse, Brachyvision, Odyssey, and Multiplan treatment planning systems, clinical delivery and quality assurance of IMPT, IMRT, SBRT, SRS and HDR brachytherapy. While at Mayo Clinic I was: the physics liaison to the radiation oncology GU disease site group, provided technical oversight of the radiation oncology departments informatics efforts, worked collaboratively with dosimetrists on proton therapy planning, worked collaboratively with Information Technology personnel to support clinical information systems, performed quality assurance of proton therapy plans, and quality assurance of proton therapy delivery systems.

      Education & Training

      Degree-Granting Education

      2006Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana, US, Resident in Medical Physics
      2004Department of Physics, Indiana University, Bloomington, Indiana, US, Ph.D. in Nuclear Physics
      2001Department of Physics, Indiana University, Bloomington, Indiana, US, M.S. in Physics
      1999Eastern New Mexico University, Portales, New Mexico, US, BS in Physics

      Postgraduate Training

      2015-2015NIH Funded Fellowship, Big Data Coursework for Computational Medicine, University of Minnesota, Rochester, Minnesota

      Licenses & Certifications

      2019Medical Physicist
      2010American Board of Radiology, Therapeutic Medical Physics

      Experience & Service

      Other Professional Positions

      Senior Faculty, Baylor College of Medicine, Houston, TX, 2019 - 2020

      Assistant Professor of Medical Physics, Mayo Clinic College of Medicine and Science, Rochester, MN, 2015 - 2019

      Consultant, Department of Radiation Oncology, Mayo Clinic, Rochester, MN, 2015 - 2019

      Senior Associate Consultant, Division of Medical Physics, Department of Radiation Oncology, Mayo Clinic, Rochester, MN, 2012 - 2015

      Physicist, Department of Radiation Oncology, Wellstar Health Systems, Marietta, GA, 2006 - 2012

      Research Assistant, Department of Physics, Indiana University, Indianapolis, IN, 2000 - 2004

      Associate Instructor, Department of Physics, Indiana University, Indianapolis, IN, 1999 - 2000

      Extramural Institutional Committee Activities

      Member, Radiation Oncology Clinical Research Council, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, Radiation Oncology Nomenclature Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, ROSI Faculty Seed Award Review Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Editorial Activities

      Associate Section Editor, Physics Section, Advances in radiation oncology, 2024 - Present

      Professional Memberships

      International Atomic Energy Agency, TRS-398PR working group

      2024 - Present

      AAPM Task Group 350

      2021 - Present

      Cyberknife Society

      2006 - 2012

      American Association of Physicists in Medicine

      2004 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2017. Multi-Institutional Pediatric Treatment Planning Project. Conference. Multi-Institutional Pediatric Treatment Planning Project. Chicago, IL, US.
      2. 2016. Creating a WPF based Eclipse API user interface to display proton therapy spot delivery patterns. Conference. Creating a WPF based Eclipse API user interface to display proton therapy spot delivery patterns. Washington, CT, US.
      3. 2014. Collision Avoidance Simulator. Conference. Collision Avoidance Simulator. Austin, TX, US.
      4. 2011. Radiobiology and Radiation Physics of the CyberKnife System as Compared to Standard Radiation Therapy. Conference. Radiobiology and Radiation Physics of the CyberKnife System as Compared to Standard Radiation Therapy, CA, US.
      5. 2009. Reducing Monitor Units and Improving Plan Quality by using Combined Isocentric and Conformal Collimators as Opposed to Conformal Collimators Alone. Conference. Reducing Monitor Units and Improving Plan Quality by using Combined Isocentric and Conformal Collimators as Opposed to Conformal Collimators Alone. Hollywood, FL, US.
      6. 2007. Axxent Electronic Brachtherapy System Implementation Experience at Wellstar Keeneston Hospital, Xoft Vendor Presentation. Conference. Axxent Electronic Brachtherapy System Implementation Experience at Wellstar Keeneston Hospital, Xoft Vendor Presentation. Minneapolis, MN, US.
      7. 2003. Axial Spin Observables in dp Breakup. Conference. Axial Spin Observables in dp Breakup. Tucson, AZ, US.
      8. 2002. Polarization Observables in pd-Breakup. Conference. Polarization Observables in pd-Breakup. East Lansing, MI, US.

      International Presentations

      1. 2026. UTILIZING CONTAINER TECHNOLOGIES TO CREATE A CONSISTENT AND PORTABLE MONTE CARLO COMPUTATION ENVIRONMENT FOR PARTICLE THERAPY. Conference. 64th Annual PTCOG Conference. Deauville, FR.
      2. 2026. “Efficient Commissioning of a Multi-Room Proton Therapy Center". Invited. Online Seminar Series for Chinese Medical Physicists. Shenzhen, CN.
      3. 2025. “The Daisy Plot” a clinically intuitive plan quality metric. Visiting. Visiting professorship at Mayo Clinic. Rochester, US.
      4. 2024. Code of Practice for Proton and Light Ion Beams. Invited. Joint IAEA and Argonne National Laboratory Training Activity on Implementation of dosimetry codes of practice for Absorbed dose determination in external beams (TRS-398 Rev.1) and Brachytherapy (TRS-492). Houston, US.
      5. 2021. Learning from the MD Anderson experience -how to manage moving targets?. Conference. Learning from the MD Anderson experience -how to manage moving targets?. Delft, NL.
      6. 2017. Is Pelvic node coverage adequate when intraprostate carbon markers are used in the daily set-up of intensity-modulated proton therapy (IMPT)?. Conference. Is Pelvic node coverage adequate when intraprostate carbon markers are used in the daily set-up of intensity-modulated proton therapy (IMPT)?. Tokoy, JP.
      7. 2017. Collecting outcomes data and developing analytics at one institution. Conference. Collecting outcomes data and developing analytics at one institution. Sapporo, JP.
      8. 2014. Proton dose computation from conebeam CT data for prostate radiotherapy planning utilzing histogram binning. Conference. Proton dose computation from conebeam CT data for prostate radiotherapy planning utilzing histogram binning. Shanghai, CN.
      9. 2013. Minimizing the effect of delayed charge on the dose delivered with a synchrotron based discrete spot scanning proton beam. Conference. Minimizing the effect of delayed charge on the dose delivered with a synchrotron based discrete spot scanning proton beam. Essen, DE.

      Formal Peers

      1. 2020. Medical Physics: Professional Development for Beginning Physicists. Invited. San Marcos, TX, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - Present
      Title:Online Adaptive Proton Therapy
      Funding Source:NIH
      Role:Co-I
      ID:R01EB293388
      Date: 2025 - Present
      Title:Dose Linear-Energy-Transfer Volume
      Funding Source:NIH
      Role:Co-I
      ID:R01CA280134
      Date: 2021 - 2023
      Title:Varian MD Anderson Alliance
      Funding Source:Industry
      Role:Project Leader
      Date: 2014 - 2016
      Title:Anthropomorphic Verification of the Eclipse AAA and Acuros Algorithms for Spine SBRT Treatments Involving Metallic Implants
      Funding Source:Small Grants Program (SGP)
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Leone, A, Peterson, CB, Lee, A, Garden, AS, Gunn, GB, Mayo, LL, Moreno, AC, Frank, SJ, Fuller, C, Reddy, JP, Hoffman, K, Vazquez, I, Yang, M, Niedzielski, JS, Court, LE, Whitaker, TJ. Defining a Quantitative Threshold for Adaptive Re-planning using a Percentile-based Scoring System. International Journal of Particle Therapy 19, 2026. e-Pub 2026. PMID: 41737863.
      2. Jia, X, Rong, Y, Wu, Q, Cardenas, CE, Court, LE, Hrinivich, WT, Kang, H, Kovalchuk, N, Whitaker, TJ, Xiao, Y, Zhang, P, Chen, Q. NRG Oncology Assessment of Artificial Intelligence for Automatic Treatment Planning in Radiation Therapy Clinical Trials. International Journal of Radiation Oncology Biology Physics 123(1):282-295, 2025. e-Pub 2025. PMID: 40164355.
      3. Song, B, Whitaker, TJ, Gautam, A, Olberg, S, Choi, BS, Lee, SU, Jeong, JH, Kim, J, Liang, X, Tan, J, Lu, B, Yaddanapudi, S, Furutani, KM, Beltran, C, Park, JC. Redundancy-weighted FDK reconstruction for dual-detector combined-scanning CBCT. Medical physics 52(8), 2025. e-Pub 2025. PMID: 40781831.
      4. Marquez, B, Fuentes, DA, Peterson, CB, Rhee, DJ, Douglas, RJ, Mumme, R, Jhingran, A, Pollard-Larkin, JM, Prajapati, S, Whitaker, TJ, Court, LE. Automatic contour quality assurance using deep-learning based contours. Physics in medicine and biology 70(14), 2025. e-Pub 2025. PMID: 40532726.
      5. Tang, X, Beltran, C, Furutani, KM, Gilson, GS, Gustafson, J, Herman, MG, Ito, S, Johnson, JE, Kruse, JJ, Long, KM, Mundy, DW, Remmes, N, Tasson, A, Whitaker, TJ, Matysiak, W, Tryggestad, E. Enhancing proton therapy quality assurance with custom-designed Octopoint phantom and Gafchromic film. Journal of applied clinical medical physics 26(7), 2025. e-Pub 2025. PMID: 40657664.
      6. Cao, W, Gronberg, M, Bilton, S, Baroudi, H, Gay, SS, Peeler, CR, Liao, Z, Whitaker, TJ, Hoffman, K, Court, LE. Dose prediction via deep learning to enhance treatment planning of lung radiotherapy including simultaneous integrated boost techniques. Medical physics 52(5):3336-3347, 2025. e-Pub 2025. PMID: 39967020.
      7. Vazquez, I, Liang, D, Salazar, RM, Gronberg, M, Sjogreen, C, Williamson, TD, Zhu, XR, Whitaker, TJ, Frank, SJ, Court, LE, Yang, M. Deep learning techniques for proton dose prediction across multiple anatomical sites and variable beam configurations. Physics in medicine and biology 70(7), 2025. e-Pub 2025. PMID: 40101365.
      8. Gergelis, KR, Bai, M, Ma, J, Routman, DM, Stish, BJ, Davis, BJ, Pisansky, T, Whitaker, TJ, Choo, RC. Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate Cancer. Current Oncology 32(4), 2025. e-Pub 2025. PMID: 40277768.
      9. Leone, AO, Mohamed, AS, Fuller, C, Peterson, CB, Garden, AS, Lee, A, Mayo, LL, Moreno, AC, Reddy, JP, Hoffman, K, Niedzielski, JS, Court, LE, Whitaker, TJ. A Visualization and Radiation Treatment Plan Quality Scoring Method for Triage in a Population-Based Context. Advances in Radiation Oncology 9(8), 2024. e-Pub 2024. PMID: 38993196.
      10. Marquez B, Wooten ZT, Salazar RM, Peterson CB, Fuentes DT, Whitaker TJ, Jhingran A, Pollard-Larkin J, Prajapati S, Beadle B, Cardenas CE, Netherton TJ, Court LE. Analyzing the Relationship between Dose and Geometric Agreement Metrics for Auto-Contouring in Head and Neck Normal Tissues. Diagnostics (Basel) 14(15), 2024. e-Pub 2024. PMID: 39125508.
      11. Liu, C, Furutani, KM, Shen, J, Wan Chan Tseung, H, Tan, HQ, Li, H, Whitaker, TJ, Beltran, C, Liang, X. Investigation of dosimetric effect of beam current fluctuations in synchrotron-based proton PBS continuous scanning. Physics in medicine and biology 69(13), 2024. e-Pub 2024. PMID: 38862000.
      12. Gronberg MP, Jhingran A, Netherton TJ, Gay SS, Cardenas CE, Chung C, Fuentes D, Fuller CD, Howell RM, Khan M, Lim TY, Marquez B, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep learning-based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Med Phys 50(11):6639-6648, 2023. e-Pub 2023. PMID: 37706560.
      13. Abbasi MA, Bruno G, Di Stefano C, Garcia Bello L, Laack NN, Corbin KS, Whitaker TJ, Pellikka PA, Mutter RW, Villarraga HR. Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study. J Cardiovasc Dev Dis 10(10), 2023. e-Pub 2023. PMID: 37887865.
      14. Baroudi H, Huy Minh Nguyen CI, Maroongroge S, Smith BD, Niedzielski JS, Shaitelman SF, Melancon A, Shete S, Whitaker TJ, Mitchell MP, Yvonne Arzu I, Duryea J, Hernandez S, El Basha D, Mumme R, Netherton T, Hoffman K, Court L. Automated contouring and statistical process control for plan quality in a breast clinical trial. Phys Imaging Radiat Oncol 28:100486, 2023. e-Pub 2023. PMID: 37712064.
      15. Gronberg MP, Beadle BM, Garden AS, Skinner H, Gay S, Netherton T, Cao W, Cardenas CE, Chung C, Fuentes DT, Fuller CD, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Pract Radiat Oncol 13(3):e282-e291, 2023. e-Pub 2023. PMID: 36697347.
      16. Zhu XR, Li Y, Yang M, Whitaker TJ, Taylor PA, Zhang X, Poenisch F, Sahoo N, Liao Z, Chang JY. Stereotactic body proton therapy for early stage non-small cell lung cancer - Technical challenges and solutions: The MD Anderson experience. J Radiosurg SBRT 9(1):75-82, 2023. e-Pub 2023. PMID: 38029015.
      17. Cao W, Gronberg M, Olanrewaju A, Whitaker T, Hoffman K, Cardenas C, Garden A, Skinner H, Beadle B, Court L. Knowledge-based planning for the radiation therapy treatment plan quality assurance for patients with head and neck cancer. J Appl Clin Med Phys 23(6):e13614, 2022. e-Pub 2022. PMID: 35488508.
      18. Dougherty JM, Whitaker TJ, Mundy DW, Tryggestad EJ, Beltran CJ. Design of a 3D patient-specific collision avoidance virtual framework for half-gantry proton therapy system. J Appl Clin Med Phys 23(2):e13496, 2022. e-Pub 2022. PMID: 34890094.
      19. Ebner, DW, Eckmann, JD, Burger, KN, Mahoney, DW, Whitaker, TJ, Petersen, IA, Kisiel, J. High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract Radiotherapy. Gastro Hep Advances 1(5):746-754, 2022. e-Pub 2022. PMID: 36117548.
      20. Garant A, Spears G, Routman D, Whitaker T, Liao Z, Harmsen W, Liu A, Haddock M, Hallemeier C, Lin S, Merrell K. A Multi-institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer. Pract Radiat Oncol 11(4):e415-e425, 2021. e-Pub 2021. PMID: 33486102.
      21. Bai M, Gergelis KR, Sir M, Whitaker TJ, Routman DM, Stish BJ, Davis BJ, Pisansky TM, Choo R. Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer. Cancer Med 9(21):7925-7934, 2020. e-Pub 2020. PMID: 32931662.
      22. Manzar GS, Lester SC, Routman DM, Harmsen WS, Petersen MM, Sloan JA, Mundy DW, Hunzeker AE, Amundson AC, Anderson JL, Patel SH, Garces YI, Halyard MY, McGee LA, Neben-Wittich MA, Ma DJ, Frank SJ, Whitaker TJ, Foote RL. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. Radiother Oncol 147:64-74, 2020. e-Pub 2020. PMID: 32234612.
      23. Jethwa KR, Jang S, Mullikin TC, Harmsen WS, Petersen MM, Olivier KR, Park SS, Neben-Wittich MA, Hubbard JM, Sandhyavenu H, Whitaker TJ, Waltman LA, Kipp BR, Merrell KW, Haddock MG, Hallemeier CL. Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer. Radiother Oncol 146:29-36, 2020. e-Pub 2020. PMID: 32114263.
      24. Mutter RW, Jethwa KR, Wan Chan Tseung HS, Wick SM, Kahila MMH, Viehman JK, Shumway DA, Corbin KS, Park SS, Remmes NB, Whitaker TJ, Beltran CJ. Incorporation of Biologic Response Variance Modeling Into the Clinic: Limiting Risk of Brachial Plexopathy and Other Late Effects of Breast Cancer Proton Beam Therapy. Pract Radiat Oncol 10(2):e71-e81, 2020. e-Pub 2020. PMID: 31494289.
      25. Lester SC, Taparra K, Petersen MM, Funk RK, Blanchard MJ, Young PM, Herrmann J, Hunzeker AE, Schultz HL, McCollough C, Tasson AM, Leng S, Martenson JA, Deisher AJ, Whitaker TJ, Williamson EE, Laack NN. Electrocardiogram-Gated Computed Tomography with Coronary Angiography for Cardiac Substructure Delineation and Sparing in Patients with Mediastinal Lymphomas Treated with Radiation Therapy. Pract Radiat Oncol 10(2):104-111, 2020. e-Pub 2020. PMID: 31783172.
      26. Deisher AJ, Whitaker TJ, Beltran CJ, Foote RL, Haddock MG, Mahajan A. Technical Delivery Parameters of 2000 Proton Treatment Courses. Int J Part Ther 6(3):27-34, 2020. e-Pub 2020. PMID: 32582812.
      27. Taparra K, Lester SC, Harmsen WS, Petersen M, Funk RK, Blanchard MJ, Young P, Herrmann J, Hunzeker A, Schultz H, McCollough C, Tasson A, Leng S, Martenson JA, Whitaker TJ, Williamson E, Laack NN. Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment. Int J Part Ther 7(1):1-12, 2020. e-Pub 2020. PMID: 33094130.
      28. Mutter RW, Jethwa KR, Gonuguntla K, Remmes NB, Whitaker TJ, Hieken TJ, Ruddy KJ, McGee LA, Corbin KS, Park SS. 3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen. Radiat Oncol 14(1):211, 2019. e-Pub 2019. PMID: 31752934.
      29. Smith NL, Jethwa KR, Viehman JK, Harmsen WS, Gonuguntla K, Elswick SM, Grauberger JN, Amundson AC, Whitaker TJ, Remmes NB, Harless CA, Boughey JC, Nguyen MT, Park SS, Corbin KS, Mutter RW. Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications. Radiother Oncol 140:76-83, 2019. e-Pub 2019. PMID: 31185327.
      30. Jethwa KR, Hellekson CD, Evans JD, Harmsen WS, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier KR, Haloi R, Lowe VJ, Welch BT, Quevedo JF, Mynderse LA, Karnes RJ, Kwon ED, Davis BJ. 11C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities. Adv Radiat Oncol 4(4):659-667, 2019. e-Pub 2019. PMID: 31673659.
      31. Jethwa KR, Park SS, Gonuguntla K, Wick SM, Vallow LA, Deufel CL, Whitaker TJ, Furutani KM, Ruddy KJ, Corbin KS, Hieken TJ, Mutter RW. In Reply to Hannoun-Levi and Hannoun. Int J Radiat Oncol Biol Phys 104(5):1177-1179, 2019. e-Pub 2019. PMID: 31039420.
      32. Jethwa KR, Park SS, Gonuguntla K, Wick SM, Vallow LA, Deufel CL, Whitaker TJ, Furutani KM, Ruddy KJ, Corbin KS, Hieken TJ, Mutter RW. Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen. Int J Radiat Oncol Biol Phys 104(1):75-82, 2019. e-Pub 2019. PMID: 30583041.
      33. Johnson JE, Beltran C, Wan Chan Tseung H, Mundy DW, Kruse JJ, Whitaker TJ, Herman MG, Furutani KM. Highly efficient and sensitive patient-specific quality assurance for spot-scanned proton therapy. PLoS One 14(2):e0212412, 2019. e-Pub 2019. PMID: 30763390.
      34. Whitaker TJ, Routman DM, Schultz H, Harmsen WS, Corbin KS, Wong WW, Choo R. IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison. Int J Part Ther 5(3):11-23, 2019. e-Pub 2019. PMID: 31788504.
      35. Choo, RC, Kazemba, B, Choo, CS, Lester, SC, Whitaker, TJ. Proton Therapy for Stage IIA-B Seminoma. International Journal of Particle Therapy 5(2):50-57, 2018. e-Pub 2018. PMID: 31773034.
      36. Jethwa KR, Tryggestad EJ, Whitaker TJ, Giffey BT, Kazemba BD, Neben-Wittich MA, Merrell KW, Haddock MG, Hallemeier CL. Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes. Adv Radiat Oncol 3(3):314-321, 2018. e-Pub 2018. PMID: 30202800.
      37. Prayongrat, A, Umegaki, K, Van Der Schaaf, A, Koong, A, Lin, SH, Whitaker, TJ, McNutt, TR, Matsufuji, N, Graves, E, Mizuta, M, Ogawa, K, Date, H, Moriwaki, K, Ito, YM, Kobashi, K, Dekura, Y, Shimizu, S, Shirato, H. Present developments in reaching an international consensus for a model-based approach to particle beam therapy. Journal of radiation research 59:i72-i76, 2018. e-Pub 2018. PMID: 29529229.
      38. Prayongrat A, Umegaki K, van der Schaaf A, Koong AC, Lin SH, Whitaker T, McNutt T, Matsufuji N, Graves E, Mizuta M, Ogawa K, Date H, Moriwaki K, Ito YM, Kobashi K, Dekura Y, Shimizu S, Shirato H. Present developments in reaching an international consensus for a model-based approach to particle beam therapy. J Rad Res 59(Suppl 1), 2018. e-Pub 2018. PMID: 29538757.
      39. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL. Data collection of patient outcomes: one institution's experience. J Radiat Res 59(suppl_1):i19-i24, 2018. e-Pub 2018. PMID: 29538757.
      40. Choo R, Kazemba B, Choo CS, Lester SC, Whitaker TJ. Proton Therapy for Stage IIA-B Seminoma: A New Standard of Care for Treating Retroperitoneal Nodes. International Journal of Particle Therapy 5(2):50 - 57, 2018. e-Pub 2018.
      41. Jethwa KR, Kahila MM, Whitaker TJ, Harmsen WS, Corbin KS, Park SS, Yan ES, Lemaine V, Boughey JC, Mutter RW. Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT). Breast Cancer Res Treat 164(1):237-244, 2017. e-Pub 2017. PMID: 28417333.
      42. Fossum CC, Beltran CJ, Whitaker TJ, Ma DJ, Foote RL. Biological Model for Predicting Toxicity in Head and Neck Cancer Patients Receiving Proton Therapy. Int J Part Ther 4(2):18-25, 2017. e-Pub 2017. PMID: 31773005.
      43. Reynolds MM, Whitaker TJ, Parney IF, Kozelsky TF, Garces YI, Foote RL, Tryggestad EJ, Pulido JS. Carbon fiducials for large choroidal melanoma treated with gamma knife radiosurgery. Acta Ophthalmol 94(8):E806 - E807, 2016. e-Pub 2016. PMID: 26893172.
      44. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. Erratum to: A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol 23(Suppl 5):1059, 2016. e-Pub 2016. PMID: 27439416.
      45. Stish BJ, Pafundi DH, Hieken TJ, Whitaker TJ, Furutani KM, Jakub JW, Boughey JC, Degnim AC, McLemore LB, Mou B, Mutter RW, Park SS. Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation. Brachytherapy 15(6):796-803, 2016. e-Pub 2016. PMID: 27614660.
      46. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol 23(10):3297 - 3303, 2016. e-Pub 2016. PMID: 27334215.
      47. Grams MP, Fong de Los Santos LE, Antolak JA, Brinkmann DH, Clarke MJ, Park SS, Olivier KR, Whitaker TJ. Cadaveric verification of the Eclipse AAA algorithm for spine SBRT treatments with titanium hardware. Pract Radiat Oncol 6(2):131 - 141, 2016. e-Pub 2016. PMID: 26723553.
      48. Sio TT, Merrell KW, Beltran CJ, Ashman JB, Hoeft KA, Miller RC, Whitaker TJ, Wurgler SK, Tryggestad EJ. Spot-scanned pancreatic stereotactic body proton therapy: A dosimetric feasibility and robustness study. Phys Med 32(2):331 - 342, 2016. e-Pub 2016. PMID: 26883369.
      49. Whitaker TJ, Beltran C, Tryggestad E, Bues M, Kruse JJ, Remmes NB, Tasson A, Herman MG. Comparison of two methods for minimizing the effect of delayed charge on the dose delivered with a synchrotron based discrete spot scanning proton beam. Med Phys 41(8):081703, 2014. e-Pub 2014. PMID: 25086513.
      50. Whitaker, TJ, Beltran, C, Remmes, N, Kruse, JJ, Bues, M, Tryggestad, E, Tasson, A, Herman, MG. SU‐E‐T‐402. Medical physics 40(6):297, 2013. e-Pub 2013.
      51. Remmes, N, Whitaker, TJ, Beltran, C, Kruse, JJ, Bues, M, Herman, MG. SU‐E‐J‐30. Medical physics 40(6):156, 2013. e-Pub 2013.
      52. Brown S, Vicini F, Vanapalli JR, Whitaker TJ, Pope DK, Lyden M, Bruggeman L, Haile KL, McLaughlin MP. Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 83(3):801 - 805, 2012. e-Pub 2012. PMID: 22245195.
      53. von Przewoski B, Balewski JT, Daehnick WW, Doskow J, Haeberli W, Ibald R, Lorentz B, Pollock RE, Pancella PV, Rathmann F, Rinckel T, Saha SK, Schwartz B, Thorngren-Engblom P, Wellinghausen A, Whitaker TJ, Wise T. Analyzing powers and spin correlation coefficients for p+d elastic scattering at 135 and 200 MeV. Phys Rev C:74, 2006. e-Pub 2006.
      54. Meyer HO, Whitaker TJ, Pollock RE, Von Przewoski B, Rinckel T, Doskow J, Kuros-Zolnierczuk J, Thorngren-Engblom P, Pancella PV, Wise T, Lorentz B, Rathmann F. Axial observables in d-->p--> breakup and the three-nucleon force. Phys Rev Lett 11(93):112502, 2004. e-Pub 2004. PMID: 15447333.
      55. Kuros-Zolnierczuk J, Thorngren-Engblom P, Meyer HO, Whitaker TJ, Witala H, Golak J, Kamamda H, Nogga A, Skibinski R. Faddeev calculations of breakup reactions with realistic experimental constraints. Few Body Systems 34(259):73, 2004. e-Pub 2004.
      56. von Przewoski B, Meyer HO, Balewski J, Daehnick WW, Doskow J, Haeberli W, Ibald R, Lorentz B, Pancella PV, Pollock RE, Rathmann F, Rinckel T, Saha SK, Schwartz B, Thorngren-Engblom P, Wellinghausen A, Whitaker TJ, Wise T. Observation of spin exchange in polarized deuterium. Phys Rev A:68, 2003. e-Pub 2003.

      Review Articles

      1. Zhu, XR, Hojo, Y, Chen, M, Alsanea, FM, Poenisch, F, Li, Y, Yang, M, Zhang, X, Whitaker, TJ, Sahoo, N. Advancements in Accelerator and Beam Delivery Technology. Cancer Journal (United States) 32(2), 2026. e-Pub 2026. PMID: 41880266.
      2. Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL. A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer. Pract Radiat Oncol 9(6):410-417, 2019. e-Pub 2019. PMID: 31310815.

      Abstracts

      1. Routman DM, Whitaker TJ, Day CN, Harmsen WS, Neben-Wittich MA, Haddock MG, Hallemeier CL, Merrell K. Predictors of lymphopenia in esophageal cancer patients receiving photon or proton radiation therapy: A dosimetric analysis. Journal of Clinical Oncology 37(Suppl 4):147, 2019. e-Pub 2019.
      2. Jethwa KR, Gonuguntla K, Wick SM, Vallow LA, Deufel CL, Whitaker TJ, Furutani KM, Ruddy KJ, Hieken TJ, Corbin KS, Park SS, Mutter RW. Prospective study of 3-fraction intra-cavitary accelerated partial breast brachytherapy: early provider and patient-reported outcomes of a novel regimen. International Journal Of Radiation Oncology Biology Physics 102(3):E586, 2018. e-Pub 2018.
      3. Lester SC, Taparra K, Hunzeker A, Funk K, Blanchard M, Young P, Herrmann J, McCollough C, Tasson A, Leng S, Martenson JA, Whitaker TJ, Williamson EE, Laack NN. Sparing of the cardiac valves and left ventricle using proton therapy with ecg-gated ct with coronary angiography for the treatment of mediastinal lymphoma. International Journal Of Radiation Oncology Biology Physics 102(3):E277, 2018. e-Pub 2018.
      4. Taparra K, Lester SC, Hunzeker A, Funk RK, Blanchard M, Young P, Herrmann J, Tasson A, Leng S, Martenson JA, Whitaker TJ, Williamson EE, Laack NN. A comparison of proton and x-ray therapy for coronary artery sparing using ecg-gated ct with coronary angiography for mediastinal lymphoma. International Journal Of Radiation Oncology Biology Physics 99(Suppl 2):E242 - E243, 2018. e-Pub 2018.
      5. Garant A, Whitaker TJ, Spears GM, Harmsen WS, Liu A, Routman DM, Liao Z, Komaki RU, Mehran R, Lester SC, Haddock MG, Hallemeier CL, Lin SH, Merrell KW. A multi-institutional analysis of dosimetric predictors of toxicity following trimodality therapy for esophageal cancer. International Journal Of Radiation Oncology Biology Physics 102(3):E29, 2018. e-Pub 2018.
      6. Mullikin TC, Lester SC, Witzig T, Habermann TM, Rule WG, Daniels TB, Stish BJ, Martenson JA, Stafford SL, Whitaker TJ, Laack NN. Adverse events and patient reported outcomes from radiation therapy for Hodgkin and non-Hodgkin lymphoma in the involved site era. International Journal Of Radiation Oncology Biology Physics 102(3):E307 - E308, 2018. e-Pub 2018.
      7. Smith N, Jethwa KR, Gonuguntla K, Elswick S, Grauberger J, Amundson A, Whitaker TJ, Remmes N, Harless C, Boughey JC, Park SS, Lemaine V, Yan ES, Corbin KS, Mutter RW. Early toxicity and patient reported outcomes of post-mastectomy pencil-beam scanning proton therapy in women with immediate tissue expander breast reconstruction. International Journal Of Radiation Oncology Biology Physics 102(3):E573 - E574, 2018. e-Pub 2018.
      8. Jethwa KR, Jang S, Gonuguntla K, Evans JD, Block MS, Kumar A, Langstraat CL, Whitaker TJ, Day CN, Deufel CL, Haddock MG, Petersen IA. Lymph node-directed simultaneous integrated boost in patients with clinically lymph node-positive cervical cancer treated with definitive chemoradiation: clinical outcomes and toxicity. International Journal Of Radiation Oncology Biology Physics 102(3):E625 - E626, 2018. e-Pub 2018.
      9. Jethwa KR, Jang S, Olivier K, Park SS, Merrell KW, Martenson JA, Neben-Wittich MA, Roberts KW, Arnett ALH, Hubbard JM, Whitaker TJ, Harmsen WS, Waltman LA, Kipp BR, Grothey A, Haddock MG, Hallemeier CL. Metastasis-directed stereotactic body radiation therapy for oligometastatic colorectal cancer: a single institution experience. International Journal Of Radiation Oncology Biology Physics 102(3):E7 - E8, 2018. e-Pub 2018.
      10. Laack NN, Whitaker TJ, Harmsen WS, Amundson A, Haddock MG, Ma DJ, Vargas CE, Choo CR, Brown PD, Garces Y, Mutter RW, Petersen IA, Olivier K, Corbin KS, Anderson J, Klein K, Pumper G, Schild SE, Miller RC, Tranby BN, Foote RL. Patient-reported quality of life during photon and proton radiation therapy: results of a prospective registry of patient reported outcomes in a large-volume, multi-site practice. International Journal Of Radiation Oncology Biology Physics 102(3):E739, 2018. e-Pub 2018.
      11. Park SS, Jakub J, Mutter RW, Boughey JC, Corbin KS, Degnim A, Jr SB, Sukov W, Racz J, Merrell KW, Farley D, Furutani KM, Whitaker TJ, Hieken TJ. A novel delivery of accelerated partial breast irradiation using intraoperative brachytherapy device placement and completion of breast conservation therapy within 10 days. International Journal Of Radiation Oncology Biology Physics 99(Suppl 2):E40, 2017. e-Pub 2017.
      12. Arnett ALH, Kottschade L, Wilhite TJ, Youland RS, Hocum C, Whitaker TJ, Park SS. Toxicity of concurrent and sequential pd-1 immune check point inhibitors with conventional and hypofractionated radiation therapy in patients with metastatic disease. International Journal Of Radiation Oncology Biology Physics 99(Suppl 2):E749, 2017. e-Pub 2017.
      13. Jethwa KR, Davis BJ, Hellekson CD, Evans JD, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Jr SB, Olivier K, Haloi R, Lowe VJ, Mynderse LA, Welch TJ, Quevedo FJ, Karnes RJ, Pisansky TM. International Journal Of Radiation Oncology Biology Physics 99(Suppl 2):E242 - E243, 2017. e-Pub 2017.
      14. Beltran C, Ito S, Whitaker TJ. Treatment Planning: Statistical analysis of spot-scanning proton treatment plan dose uncertainties under multiple combinations of positional, rotational, and range errors. PTCOG:348, 2017. e-Pub 2017.
      15. Mundy D, Tryggestad E, Beltran C, Furutani K, Gilson G, Ito S, Johnson J, Kruse J, Remmes N, Tasson A, Whitaker T, Herman M. SU-F-T-169: A Periodic Quality Assurance Program for a Spot-Scanning Proton Treatment Facility. Med Phys 43(6):3500, 2016. e-Pub 2016.
      16. Hieken T, Mutter R, Jakub J, Boughey J, Degnim A, Sukov W, Childs S, Furutani K, Whitaker T, Park S. Sonic-pbi - a novel protocol to complete breast cancer surgery and radiation within 10 days. Annals Of Surgical Oncology 23(Suppl 3):81 - 82, 2016. e-Pub 2016.
      17. Anand A, Bues M, Shen J, Rule WG, Vora S, Keole SR, Vargas C, Whitaker TJ, Choo CR, Hallemeier CL, Miller RC, Ashman J. Effects of rectal variations on proton dose for treatment of rectum and anal cancers: a cone beam ct based planning study. International Journal Of Radiation Oncology Biology Physics 1(93):E573 -E574, 2015. e-Pub 2015.
      18. Grams M, Clarke M, Antolak JA, Brinkmann DH, Fong de los Santos L, Mayo C, Park SS, Olivier K, Whitaker TJ. Cadaveric verification of vmat dose distributions for spine sbrt treatments with titanium implants. International Journal Of Radiation Oncology Biology Physics 1(93):E547 - E548, 2015. e-Pub 2015.
      19. Tryggestad EJ, Sio TT, Ashman JB, Beltran CJ, Whitaker TJ, Hoeft KA, Wurgler SK, Miller RC. Aggregated plan robustness analyses for spot-scanned pancreatic stereotactic body proton therapy. Int J Radiat Oncol Biol Phys 1(90):S918, 2014. e-Pub 2014.
      20. Tasson A, Beltran C, Laack N, Childs S, Tryggestad E, Whitaker T. SU-E-T-337: Treatment Planning Study of Craniospinal Irradiation with Spot Scanning Proton Therapy. Med Phys(6):302, 2014. e-Pub 2014.
      21. Stish BJ, Hieken TJ, Pafundi DH, Whitaker TJ, Furutani KM, Mutter RW, Mou B, Mayo CS, Jakub JW, Boughey JC, McLemore LB, Hallemeier CL, Park SS. Assessment of dosimetric changes and adaptive replanning for intraoperatively placed brachytherapy applicators during accelerated partial breast irradiation. American Brachytherapy Society Annual Meeting, 2014. e-Pub 2014.
      22. Beltran C, Whitaker TJ, Tryggestad EJ, Hallemeier CL, Davis BJ, Daniels TB, Wong WW. Proton dose computation from conebeam CT data for prostate radiotherapy planning utilizing histogram binning. PTCOG, 2014. e-Pub 2014.
      23. Whitaker T, Beltran C, Remmes N, Kruse J, Bues M, Tryggestad E, Tasson A, Herman M. Comparison of two methods for minimizing the effect of delayed charge on the dose delivered with a synchrotron based discrete spot scanning proton beam. Medical Physics 40(6):297, 2013. e-Pub 2013.
      24. Remmes N, Whitaker T, Beltran C, Kruse J, Bues M, Herman M. Intuitive display coordinates for six-degree-of-freedom treatment couches. Medical Physics 40(6):156, 2013. e-Pub 2013.
      25. McLaughlin MP, Whitaker TJ, Zolty P, Reyes M, Haile K. Using CyberKnife Radiosurgery for Salvage Treatment of Locally Failed Lung Cancer after Initial Treatment with Radiotherapy/Chemotherapy. Proceedings of the 50th ASTRO Meeting, International Journal of Rad Onc, Biology, Physics(72):S445 - S446, 2008. e-Pub 2008.
      26. McLaughlin MP, Bordoni R, Whitaker TJ, Zolty P, Andrews M, Still T, Vanapalli J, Haile K. Therapy Using CyberKnife Radiosurgery in NSCLC Patients with Low-Volume Residual Disease Upon Completion of Systemic Therapy. Proceedings of the ASCO Annual Meeting(18S), 2007. e-Pub 2007.
      27. Thorngren Engblom P, Meyer HO, von Przewoski B, Kuros-Zolnierczuk J, Whitaker TJ, Doskow J, Lorentz B, Pancella PV, Pollock RE, Rathmann F, Rinckel T, Wise T, Witala H, Golak J, Kamada H, Nogga A, Skibinski R. Experimental Search for Evidence of the Three-Nucleon Force and a New Analysis Method. Proceedings of the Contribution to the 19th European Few-Body Conference, 2004. e-Pub 2004.
      28. Balewski J, Doskow J, Meyer HO, Pollock RE, von Przewoski B, Rinckel T, Wellinghausen A, Whitaker TJ, Haeberli W, Schwartz B, Wise T, Lorentz B, Rathmann F, Pancella PV. Vector and Tensor Polarized Deuterium Target at the IUCF Cooler. Proceedings of the American and Japanese Physical Societies, 2001. e-Pub 2001.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 13, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top